Related Experiment Video

Updated: Sep 18, 2025

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology
05:51

A Human Ex Vivo Atherosclerotic Plaque Model to Study Lesion Biology

Published on: May 6, 2014

13.3K

Immunotherapy for the Treatment of Atherosclerotic Disease: Integrative Review

Lenize da Silva Rodrigues1,2, Matheus Bertanha1,2

  • 1School of Medicine, Botucatu, Sao Paulo State University - UNESP, Botucatu, Brazil.

Monoclonal Antibodies in Immunodiagnosis and Immunotherapy
|June 25, 2025
PubMed

Immunotherapy, especially monoclonal antibodies, has shown efficacy in modulating the inflammatory response and controlling lipidic pathways, offering new approaches for treating atherosclerotic disease. This article reviews the scientific evidence on the use of therapeutic monoclonal antibodies in treating atherosclerotic disease. An integrative review was carried out using the protocol Whittemore and Knafl framework and the PRISMA 2020 guidelines for systematic reviews. We analyzed clinical trials using monoclonal antibody immunotherapy to treat atherosclerosis. This review used the relevant articles published in Scopus, Embase, PubMed, Cochrane, Web of Science, Scielo, BVS, and Cinhal databases. The period of publication studies that was selected was between 2015 and 2025. Results: 277 articles were identified. One hundred and 22 studies were in duplicate and were excluded. After the complete reading of the studies, only 20 clinical studies were included in this review, both randomized and nonrandomized. Monoclonal antibody immunotherapy presents an innovative approach to treating atherosclerosis by targeting inflammation and lipidic pathway factors. However, these treatments need to be thought out individually, and further research is required to optimize them, minimize risks, and address cost challenges. Combining immunotherapy with other therapies could promote a significant advancement in atherosclerosis management.

Keywords:
atherosclerosishypercholesterolemiahyperlipidemiaimmunotherapymonoclonal antibodies

More Related Videos

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice09:06

Quantitative Analysis of Cellular Composition in Advanced Atherosclerotic Lesions of Smooth Muscle Cell Lineage-Tracing Mice

Published on: February 20, 2019

8.4K
Flow Cytometry Analysis of Immune Cells Within Murine Aortas15:15

Flow Cytometry Analysis of Immune Cells Within Murine Aortas

Published on: July 1, 2011

34.8K

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
42
Atherosclerosis I: Introduction01:30

Atherosclerosis I: Introduction

Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
93
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
675
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
34
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
65
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
42